NYLT
AMGN icon

New York Life Trust’s Amgen AMGN Stock Holding History

New York Life Trust’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4K Sell
22
-762
-97% -$127K 0.19% 128
2016
Q4 		$115K Buy
784
+160
+26% +$24.1K 0.55% 55
2016
Q3 		$104K Buy
624
+221
+55% +$37.4K 0.51% 58
2016
Q2 		$61K Sell
403
-351
-47% -$54.6K 0.3% 119
2016
Q1 		$113K Sell
754
-810
-52% -$120K 0.49% 58
2015
Q4 		$254K Sell
1,564
-102
-6% -$16K 1.09% 23
2015
Q3 		$230K Buy
1,666
+2
+0.1% +$315 1.02% 22
2015
Q2 		$255K Sell
1,664
-67
-4% -$10.7K 1.06% 22
2015
Q1 		$277K Buy
1,731
+188
+12% +$29.6K 1.1% 18
2014
Q4 		$246K Buy
1,543
+1,128
+272% +$176K 0.97% 25
2014
Q3 		$58K Buy
415
+296
+249% +$38.6K 0.24% 138
2014
Q2 		$14K Sell
119
-1,233
-91% -$143K 0.06% 168
2014
Q1 		$167K Sell
1,352
-451
-25% -$54.7K 0.74% 34
2013
Q4 		$206K Buy
1,803
+22
+1% +$2.5K 0.94% 25
2013
Q3 		$199K Sell
1,781
-289
-14% -$31.3K 1% 23
2013
Q2 		$204K Buy
+2,070
New +$215K 0.94% 22

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York Life Trust's AMGN Position: Q1 2017 in Review

New York Life Trust reduced its Amgen (AMGN) stake by 97% in Q1 2017, selling an estimated $127K and leaving 22 shares worth $4K. The position accounts for 0.19% of the portfolio, ranked #128.

New York Life Trust first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $277K in Q1 2015. 1,601 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • New York Life Trust held 22 shares of Amgen worth $4K as of Q1 2017.
  • New York Life Trust sold 762 Amgen shares in Q1 2017, an estimated $127K.
  • Amgen made up 0.19% of New York Life Trust's portfolio in Q1 2017, its #128 holding.
  • New York Life Trust first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Amgen position peaked at $277K in Q1 2015.
  • 1,601 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.